tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Suji Jeong, 17 are a BUY (80.95%), 4 are a HOLD (19.05%).
Analyst Suji Jeong, carries an average stock price target met ratio of 42.5% that have a potential upside of 21.02% achieved within 309 days. Previously, Suji Jeong worked at JEFFERIES.
Suji Jeong’s has documented 41 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on VRNA, Verona Pharma PLC ADR at 09-Jul-2025.
Analyst best performing recommendations are on INZY (INOZYME PHARMA).
The best stock recommendation documented was for INZY (INOZYME PHARMA) at 3/23/2023. The price target of $6 was fulfilled within 26 days with a profit of $2.7 (81.82%) receiving and performance score of 31.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-May-2023
$14.75
$0.01 (0.07%)
$14.75
3 years 4 months 19 days ago
(15-May-2023)
4/7 (57.14%)
$0.28 (1.94%)
151
Buy Since 30-Sep-2019
$14.75
$0.01 (0.07%)
3 years 5 months 15 days ago
(19-Apr-2023)
1/2 (50%)
$0.31 (2.15%)
68
Buy Since 18-Nov-2020
$14.75
$0.01 (0.07%)
3 years 5 months 16 days ago
(18-Apr-2023)
2/2 (100%)
$0.31 (2.15%)
349
Buy Since 13-Dec-2021
$14.75
$0.01 (0.07%)
$15
3 years 5 months 16 days ago
(18-Apr-2023)
1/2 (50%)
$0.31 (2.15%)
69
Buy Since 26-Jun-2020
$20
$5.26 (35.69%)
$20
3 years 6 months 12 days ago
(22-Mar-2023)
2/6 (33.33%)
$12.23 (157.40%)
480
